Analysis News

In-depth stock market analysis, technical indicators, and investment commentary. Expert insights on market trends, valuations, and trading strategies.

Joby's Autonomous Flight Milestone Fails to Lift Shares
Analysis Daniel Marsh

Joby's Autonomous Flight Milestone Fails to Lift Shares

Joby Aviation's stock slipped 1.13% after a long autonomous flight in a Cessna, not its eVTOL, leaving investors focused on certification progress.

JOBY ACHR
EA's Madden NFL 27 Patch Aims to Shore Up Live Services After Buyout
Analysis Daniel Marsh

EA's Madden NFL 27 Patch Aims to Shore Up Live Services After Buyout

EA's latest Madden NFL 27 patch targets transaction and progression glitches as the company navigates post-buyout debt and live-service revenue pressures.

EA TTWO RBLX
Coca-Cola's Premium Valuation Faces a Narrow Path to Analyst Targets
Analysis Daniel Marsh

Coca-Cola's Premium Valuation Faces a Narrow Path to Analyst Targets

Coca-Cola (KO) shares have rallied 11% in three months to $88.25, leaving only 7.3% upside to the average analyst target. With a forward P/E of 26x, the stock's premium valuation leaves little room for error.

KO PEP MNST COCO
McDonald's and Wendy's App Deals Reveal Loyalty Divide
Analysis Daniel Marsh

McDonald's and Wendy's App Deals Reveal Loyalty Divide

McDonald's and Wendy's both ran app-gated burger deals, but their loyalty programs are worlds apart. McDonald's has scale; Wendy's is in turnaround mode.

MCD WEN
Novo Nordisk Faces Semaglutide Test at Capital Markets Day
Analysis Daniel Marsh

Novo Nordisk Faces Semaglutide Test at Capital Markets Day

Novo Nordisk's Capital Markets Day on Monday will test its strategy as semaglutide dominates sales. Stock closed at $43.24, with analysts split on valuation.

NVO
MIS Stock Drops 3.1% as Final HUMAIN Deal Nears SAR 9B
Analysis Daniel Marsh

MIS Stock Drops 3.1% as Final HUMAIN Deal Nears SAR 9B

MIS shares fell 3.1% after finalizing a SAR 8.76B data-center agreement, nearly seven times its 2025 revenue. Revenue recognition depends on sequential work orders.

ExxonMobil Eyes Venezuela Return as Shares Hold Steady
Analysis Daniel Marsh

ExxonMobil Eyes Venezuela Return as Shares Hold Steady

ExxonMobil is negotiating a possible return to Venezuela's Orinoco Belt, with shares barely moving. Investors await deal terms, not barrel counts.

XOM CVX COP
Fidelity Reports Record IRA Balances as Contributions Surge 36%
Analysis Daniel Marsh

Fidelity Reports Record IRA Balances as Contributions Surge 36%

Fidelity's average IRA balance reached a record $144,523 in Q2 2026, driven by strong markets and a 36% jump in contributions.

SCHW TROW VOYA
AMD Radeon RX 10800 XT Rumors Unverified; Gaming Segment Slips
Analysis Daniel Marsh

AMD Radeon RX 10800 XT Rumors Unverified; Gaming Segment Slips

AMD's unconfirmed RX 10800 XT claims lack official backing. Gaming revenue dropped 31% to $779M, just 6.8% of Q2 sales, while data center leads growth.

AMD NVDA
Oracle's $18B Data-Center Debt Stirs Financing Worries
Analysis Daniel Marsh

Oracle's $18B Data-Center Debt Stirs Financing Worries

Oracle's $18B data-center loans for Project Jupiter are quoted at 89-91 cents, raising financing concerns as shares fell 1.98% to $147.61.

ORCL JEF SAN
Sony's Underworld Franchise Stays Dormant as Library Asset; No Sequel on Slate Through 2027
Analysis Daniel Marsh

Sony's Underworld Franchise Stays Dormant as Library Asset; No Sequel on Slate Through 2027

Sony's Underworld series, 23 years old, remains a library asset with no sequel planned through June 2027. The franchise's $542.9M box office and Sony Pictures' strong margins underscore its strategic value.

SONY DIS
Rocket Lab Slides 4.8% as Iridium Deal Faces Regulatory Hurdles
Analysis Daniel Marsh

Rocket Lab Slides 4.8% as Iridium Deal Faces Regulatory Hurdles

Rocket Lab shares dropped 4.8% Friday after a $1.94B capital raise, with Iridium deal still pending FCC review and shareholder vote.

RKLB IRDM ASTS LUNR